Overcoming vaccine hesitancy in low-income and middle-income regions

Clarissa Simas¹, Heidi J Larson^{2

3}

Affiliations

¹ Department of Infection Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. clarissa.simas@lshtm.ac.uk.
² Department of Infection Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
³ Department of Health Metrics Science, University of Washington, Seattle, WA, USA.

Clarissa Simas et al. Nat Rev Dis Primers. 2021.

. 2021 Jun 10;7(1):41.

doi: 10.1038/s41572-021-00279-w.

Clarissa Simas¹, Heidi J Larson^{2

3}

¹ Department of Infection Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. clarissa.simas@lshtm.ac.uk.
² Department of Infection Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
³ Department of Health Metrics Science, University of Washington, Seattle, WA, USA.

No abstract available

References

1. World Health Organization. Ten threats to global health in 2019. who.int https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-... (2019).
1. MacDonald, N. E. et al. Vaccine hesitancy: Definition, scope and determinants. Vaccine 33, 4161–4 (2015). - DOI
1. Bhopal, S. & Nielsen, M. Vaccine hesitancy in low- and middle-income countries: Potential implications for the COVID-19 response. Arch. Dis. Child. 106, 113–114 (2021). - DOI
1. Wellcome Trust. Wellcome Global Monitor 2018 Report. Perceived safety and effectiveness of vaccines by regions. wellcome.ac.uk https://wellcome.ac.uk/reports/wellcome-global-monitor/2018 [Accessed May 15 2021].
1. Africa Centres for Disease Control and Prevention. COVID 19 Vaccine Perceptions: A 15 country study. February 2021. africacdc.org https://africacdc.org/download/covid-19-vaccine-perceptions-a-15-country... (2021).